Innovative biochemicals, antibodies and custom services for the life science researcher

Overview

 
Innovative biochemicals, antibodies and custom services for the life science researcher.
AFFINITI specialises in the research, development, manufacture and supply of high quality and innovative products and services for the life scientist with particular focus being placed on neuroscience, signal transduction and cell biology.


AFFINITI's headquarters on the outskirts of London, UK

In addition to its own range of products and services, AFFINITI distributes and technically supports products throughout the United Kingdom, Republic of Ireland and most territories of Europe for six US-based companies, namely Transduction Laboratories, Biomeda Research Laboratories, Inc., Genprice Inc., Immunetics, Inc., Caslab, Inc. and Maxanim, Inc.

 BIOMOL is subsidiary of Affiniti

BIOMOL International provides specialised reagents for :

cell biological research  (including antibodies, peptides, enzymes, enzyme activators and inhibitors, second messengers, and assay kits as well as a comprehensive offering of bioactive lipids and neuropharmacologics) and a range of compound libraries for screening.  Innovative products also include a wide range of products for neuroscience research  and the most comprehensive range of substrates, inhibitors, enzymes, proteins and antibodies 


In addition to its own extensive range of biochemical and immunochemical products for cell biological research (particularly in neuroscience and ubiquitin-proteasome areas) and its widely respected experience and expertise in peptide synthesis, conjugate preparation, antiserum production, and antibody purification, AFFINITI distributes and technically supports products throughout the United Kingdom, Republic of Ireland and certain territories of Europe for two US-based companies, namely

BIOMOL International LP has been formed by merger of BIOMOL Research Laboratories Inc of Plymouth Meeting, PA, USA and AFFINITI Research Products Ltd in order to provide innovative biochemicals, antibodies and custom services to the life science researcher worldwide.  ​

The BIOMOL International worldwide network offers specialised reagents for signal transduction research (including antibodies, peptides, enzymes, enzyme activators and inhibitors, second messengers, and assay kits as well as a comprehensive offering of bioactive lipids and neuropharmacologics) and a range of compound libraries for screening (previously available from BIOMOL Research Laboratories) with the innovative products and services for cell biological research available from AFFINITI. This includes a wide range of products for neuroscience research and the world's most comprehensive range of substrates, inhibitors, enzymes, proteins and antibodies for use in ubiquitin, proteasome and COP9-signalosome research. AFFINITI staff also specialise in the manufacture of high quality synthetic peptides and in the synthetic peptide approach to protein-reactive antibody production

Affini-T Therapeutics : 

Pioneering Breakthroughs in Cellular Immunotherapy

Affini-T Therapeutics, Inc. is at the forefront of cellular immunotherapy, advancing cutting-edge treatments for cancer and genetic disorders. By leveraging advanced immuno-oncology therapies, Affini-T is making significant strides in personalized medicine with a focus on T-cell engineering and targeted immune response.​

Affini-T’s Cutting-Edge Immunotherapy Solutions

  • T-Cell Engineering for Cancer Immunotherapy

Affini-T Therapeutics is making great strides in T-cell engineering for immuno-oncology therapies. By modifying the patient’s T-cells to recognize and attack cancer cells, Affini-T is creating personalized and effective treatments for various types of cancer, including solid tumors and hematologic malignancies. These innovative therapies enable the immune system to specifically target and destroy cancer cells while minimizing harm to normal, healthy cells.

  • Next-Generation Gene Editing

Using advanced gene editing technologies, Affini-T’s platform allows for precision-based T-cell modification, creating a robust immune response against cancerous cells. Their work in CRISPR and other gene-editing techniques ensures that each therapy is uniquely tailored to the patient's genetic profile.

  • Targeted Immunotherapy

Affini-T’s proprietary therapies are designed to deliver highly targeted treatments to specific areas of the body. This reduces the risk of side effects commonly associated with traditional therapies like chemotherapy and radiation, making it a more effective and patient-friendly approach to cancer treatment.

Why Choose Affini-T Therapeutics for Cancer Treatment?

  •  Innovative T-Cell Engineering

The affiniti platform leverages cutting-edge technology to genetically modify T-cells for personalized cancer treatment.

  • Precision Immuno-Oncology

Affini-T is leading the way in targeted immunotherapies, offering precision treatments tailored to the individual genetic makeup of each patient’s cancer.

  • Proven Efficacy

Affini-T's therapies show promising results in early-stage clinical trials, demonstrating high efficacy in targeting cancer cells while reducing off-target effects and toxicities.

Applications of Affini-T Therapeutics in Immuno-Oncology

  • Solid Tumors: Affini-T's immunotherapy is effective against a range of solid tumors, providing a much-needed alternative to traditional cancer treatments.
  • Hematologic Malignancies: The affiniti platform has shown exceptional results in targeting blood cancers, including leukemia and lymphoma.
  • Genetic Disorders: Affini-T’s work extends beyond cancer, with potential applications for the treatment of genetic diseases through gene therapy and T-cell modulation.

The Future of Cancer Therapy with Affini-T

As Affini-T Therapeutics, Inc. continues to develop innovative T-cell therapies, the future of immuno-oncology looks brighter than ever. Their commitment to personalized medicine, gene editing, and cellular immunotherapy will no doubt change the way we approach cancer treatment in the coming years.

Affini-T Therapeutics is leading the way in next-generation cancer therapies, providing hope to those who have exhausted traditional treatment options. With their scientific expertise, cutting-edge technology, and commitment to patient care, Affini-T is paving the path for a new era in cancer treatment.